March 20, 2025
The Reality of Federal Cannabis Legalization

Cannabis businesses operate in a peculiar legal environment, unlike any other industry in American history. While 39 states have legalized medical cannabis and 24 permit recreational use, federal cannabis legalization compliance remains a significant challenge as the substance is still classified as Schedule I. This contradiction creates substantial hurdles for legitimate businesses trying to operate […]

Read More
February 4, 2025
Challenging Cannabis Compliance Standards: What Businesses Need to Know

Cannabis businesses face a unique challenge when developing new products: meeting differing state regulatory cannabis compliance standards. Even if a product complies with current regulations, there’s always a risk that those standards could change, potentially impacting the product's legality. The Authority Behind Cannabis Regulations State regulators derive their authority from legislatures, giving them the power […]

Read More
December 19, 2024
GMP Certification in Cannabis: Why It's Becoming the Industry Gold Standard

As the cannabis industry matures, Good Manufacturing Practice (GMP) certification is emerging as a crucial differentiator between companies that will thrive and those that may struggle to compete. During a recent Qredible Live broadcast, Darwin Millard, Technical Director at Cannabis Safety and Quality (CSQ), shared how GMP certification is changing cannabis manufacturing and creating new […]

Read More
November 14, 2024
Cannabis Rescheduling in 2024: Understanding the Investment and Operational Impact

The potential rescheduling of cannabis from Schedule I to Schedule III represents one of the most anticipated regulatory changes in 2024. During a recent Qredible Live webinar, Mike Goral of Armanino LLP and Colin Campbell of Campfire Advisors shared insights about the complex realities behind this potential shift and what it means for cannabis businesses. […]

Read More
November 5, 2024
COA Management for CBD Companies

While Certificates of Analysis (COAs) may seem like routine paperwork, savvy CBD companies are discovering their power as strategic tools for business growth. Gone are the days when these laboratory documents merely satisfied basic compliance requirements. Today's successful CBD companies leverage efficient COA management and their own COAs as valuable business intelligence tools that inform […]

Read More
February 28, 2024
ASTM International Committee Week Recap: A Conversation with David Vaillencourt

We recently sat down with David Vaillencourt of S3 Collective to discuss the highlights from the ASTM International Committee Week, which recently took place in Louisville, Kentucky. Read the transcript below or watch the video on YouTube. Qredible: Welcome to this week's Qredible live broadcast. We're joined by our CEO, Brian Fitzpatrick, and David Vaillencourt. […]

Read More
January 24, 2024
Cannabis Industry Standards: A Conversation with David Vaillencourt

We recently sat down with David Vaillencourt, a cannabis industry standards expert, to discuss his work in developing frameworks of safety, quality, and compliance in cannabis. Read the transcript below or watch the video. Qredible: Welcome to the Qredible Live Broadcast! I'm speaking with David Vaillencourt, a cannabis industry standards expert and founder of S3 […]

Read More
crossmenu